|
WO9426251A1
|
|
Subcutaneous liposome delivery method
|
|
AU6368394A
|
|
Polymer-polypeptide composition and method
|
|
US5534259A
|
|
Polymer compound and coated particle composition
|
|
US5395619A
|
|
Lipid-polymer conjugates and liposomes
|
|
US5356633A
|
|
Method of treatment of inflamed tissues
|
|
AU2473092A
|
|
HIV-treatment method with low-toxicity amphotericin B
|
|
US5194266A
|
|
Amphotericin B/cholesterol sulfate composition and method
|
|
WO9203123A1
|
|
Liposome alternative bilayer formulations
|
|
CA2088975A1
|
|
Stable doxorubicin/liposome composition
|
|
EP0527940A1
|
|
Direct spray-dried drug/lipid powder composition
|
|
US5180713A
|
|
Stabilized liposome/amphotercin B composition and method
|
|
US5225212A
|
|
Microreservoir liposome composition and method
|
|
US5185154A
|
|
Method for instant preparation of a drug containing large unilamellar vesicles
|
|
AU4752490A
|
|
A novel nonphospholipid liposome composition for sustained release of drugs
|
|
WO9006775A1
|
|
A novel nonphospholipid liposome composition for sustained release of drugs
|
|
US5192528A
|
|
Corticosteroid inhalation treatment method
|
|
US5013556A
|
|
Liposomes with enhanced circulation time
|
|
US5340587A
|
|
Liposome/bronchodilator method & System
|
|
US5064655A
|
|
Liposome gel composition and method
|
|
US5023087A
|
|
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
